Synmosa Group and National Yang-Ming University signed MOU on Pharmaceutical Scientist Scholarship Program

PharmaceuticalScientistScholarshipMOUSigningCeremo...

Synmosa to consolidate hold on Health Chemical in 128 million deal

Date:2017.9.29 TheSynmosaBiopharmaCorporation(4...

Synmosa and EA Pharma announced License Agreement of Patented New Drug for Constipate

SynmosaBiopharmahasbeensuccessfullyin-licensedpate...

Synmosa Acquires Over 90% Majority Stake in Seven Star Pharmaceutical

Date:2016.11.28 Inthewakeofacollaborationbetwee...

Synmosa Biopharma Inks NT$210 million Licensing Agreement for Budesonide

Date:2016.08.04 SynmosaBiopharma(TPEx:4114)toda...

Synmosa's Posts Highest Single-Quarter Earnings Ever, EPS Hits NT$1.35

Date:2016.05.09 SynmosaBiopharma(TPEx:4114)rece...

Synmosa Signs NT$420 million Deal with Hemony Pharma

Date:2016.05.03 Inlessthansixmonths,SynmosaBiop...

Synmosa Collaborates with InnoPharmax to Branch Out into Production of API

Date:2016.03.24 SynmosaBiopharma(TPEx:4114)toda...

Synmosa Group Achieves Rapid Growth, Posts Revenue of Over NT$200 Million in a Single Month

Date:2016.02.15 SynmosaBiopharma(TPEx:4114)toda...

Synmosa Group Subsidiary Ningbo Youhe Awarded GSP Certification

Date:2016.01.06 SynmosaBiopharma(TPEx:4114)toda...

Synmosa Plant Passes Inspection by South Korea's Ministry of Food and Drug Safety

Date:2015.11.17 SynmosaBiopharma(TPEx:4114)anno...

Synmosa and Kyorin announced License Agreement of Imidafenacin- Patented New Drug for OAB

Date:2015.08.31 SynmosaBiopharmahasbeensuccessf...

Synmosa announced new logo and new visual brand identity

Synmosaproudlyunveiledournewcorporateidentitywitha...

Synmosa Group Acquires Health Chemical Pharmaceutical Corp.

Date:2014.04.16 SynmosaGroupannouncestoacquirea...

Synmosa 2012 Q3 revenues hit a historical high of NT$2.5 billion